Annovis Bio, Inc.ANVSNYSE
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank75
3Y CAGR+66.3%
5Y CAGR-6.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+66.3%/yr
vs +625.4%/yr prior
5Y CAGR
-6.5%/yr
Recent acceleration
Acceleration
-559.0pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$841061.00-60.0%
2024$2.10M+118.8%
2023$-11.17M-6212.9%
2022$182712.00+264.8%
2021$50089.00-95.7%
2020$1.18M+91.7%
2019$614642.00+931175.8%
2018$66.00-21.4%
2017$84.00-